Adult epithelial stem cell-derived organoids (HUB Organoids™) are proving to be a major breakthrough in preclinical models. HUB Organoids are fundamentally changing the way drug discovery and development can be performed and generate the exciting possibility of accurately predicting which treatment would benefit each patient the most by testing multiple treatments in parallel.


Have any questions?

contact us